Back to Blog
Why Dove Medical Press?
Introducing the Dove Medical Press blog
Tim Hill on November 7, 2012 at 9:51 am
With this blog we intend to feature the opinions and commentaries of our esteemed journal Editors-in-Chief and key publishing staff. With over 125 journals publishing 10,000+ articles, we do not expect a shortage of interesting reading. The entries will consist of timely developments in a collection of fields, including science, technology and medicine. We are excited about this new development. Our goal is to give our journal Editors-in-Chief avenue to inform their authors and readers about industry goings-on, as well as to provide them a chance to interact with each other. Likewise with blog entries from myself and other key staff, which I trust will be of interest and create some robust discussion.
For November 2012, we introduce Professor Thomas Webster and Dr. Richard Walker. Dr. Walker will discuss sarcopenia and its significance in longevity medicine, while Professor Webster addresses a common question: Has the field of nanomedicine matured?
Dr. Walker is Editor-in-Chief for Clinical Interventions in Aging. He has broad experience in the theoretical and practical aspects of aging research derived from key positions in academia and industry. His education includes a BS in pharmacy (Rutgers University), an MS in biochemistry (New Mexico State University) and a PhD in endocrine physiology (Rutgers University). Postdoctoral training in Neuroendocrinology and Neuropharmacology of Aging was received at the Center for the Study of Aging and Human Development, Duke University Medical Center and at the University of California, Berkeley.
Dr. Walker has held academic positions in Clemson University, Sanders-Brown Research Center on Aging at the University of Kentucky Medical Center, Medical College of Pennsylvania and the University of South Florida College of Medicine. Dr. Walker successfully prepared several investigational new drug applications (IND’s) to the FDA for studying hormone replacement in aging subjects, and with his colleague Dr. Barry Bercu, has organized and co-chaired many international symposia on clinical interventions in aging.
Under Dr. Walker’s direction Clinical Interventions in Aging provides an ethical forum for presentation of data and debate on issues relevant to medical practice that is less concerned with treating intrinsic diseases of aging than with sustaining health and vitality throughout life.
Professor Webster is Department Chair and Professor, Chemical Engineering, Northeastern University, previously Associate Professor for the Division of Engineering at Brown University and the Division of Orthopedic Surgery at Brown University Medical School. He has degrees in chemical engineering from the University of Pittsburgh (BS, 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (MS, 1997; PhD, 2000).
Professor Webster’s research on nanophase materials has received attention in numerous recent media publications such as MSNBC News, June 1, 2004; the Economist, June 5, 2004; and Chemical and Engineering News, Feb 28, pp. 39–42, 2000. He has organized more than 25 symposia at academic conferences highlighting the use of nanomaterials in biological applications.
Other honors include: 2000, Karen and Lester Gerhardt Graduate Student Award in recognition of outstanding academic achievement and promise for a successful career, Rensselaer Polytechnic Institute; 2002, Biomedical Engineering Society Rita Schaffer Young Investigator Award; 2004, Purdue University Young Investigator Award from the Schools of Engineering; 2005, Finalist for the Young Investigator Award for the American Society for Nanomedicine; and 2004, Early Career Award from the Coulter Foundation.
He currently serves as the Editor-in-Chief of the International Journal of Nanomedicine and is on the Editorial Board of Biomaterials, American Society for Artificial Internal Organs, International Journal of Nanomanufacturing, and Journal of Biomedical Nanotechnology.
Publisher, Dove Medical Press